Joel Greenblatt's ZBH Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 52,832 shares of Zimmer Biomet Holdings, Inc. (ZBH) worth $4.78 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 45 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in ZBH, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2016, adding 372,168 shares. Largest reduction occurred in Q3 2016, reducing 358,418 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Zimmer Biomet Holdings (ZBH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Zimmer Biomet Holdings (ZBH) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +52,832 | New Buy | 52,832 | $90.42 |
| Q4 2025 | -39,377 | Sold Out | 0 | $0.00 |
| Q3 2025 | -49,592 | Reduce 55.74% | 39,377 | $98.50 |
| Q2 2025 | +66,829 | Add 301.85% | 88,969 | $91.21 |
| Q1 2025 | -28,687 | Reduce 56.44% | 22,140 | $113.18 |
| Q4 2024 | +40,384 | Add 386.71% | 50,827 | $105.63 |
| Q3 2024 | -58,608 | Reduce 84.88% | 10,443 | $107.95 |
| Q2 2024 | +38,528 | Add 126.23% | 69,051 | $108.53 |
| Q1 2024 | +7,017 | Add 29.85% | 30,523 | $131.98 |
| Q4 2023 | -20,599 | Reduce 46.70% | 23,506 | $121.70 |
| Q3 2023 | +706 | Add 1.63% | 44,105 | $112.22 |
| Q2 2023 | -10,660 | Reduce 19.72% | 43,399 | $145.60 |
| Q1 2023 | +48,230 | Add 827.41% | 54,059 | $129.20 |
| Q4 2022 | -43,001 | Reduce 88.06% | 5,829 | $127.50 |
| Q3 2022 | +1,662 | Add 3.52% | 48,830 | $104.55 |
| Q2 2022 | +47,168 | New Buy | 47,168 | $105.05 |
| Q1 2022 | -15,360 | Sold Out | 0 | $0.00 |
| Q4 2021 | +15,360 | New Buy | 15,360 | $123.37 |
| Q2 2021 | -1,444 | Sold Out | 0 | $0.00 |
| Q1 2021 | -3,851 | Reduce 72.73% | 1,444 | $155.12 |
| Q4 2020 | -1,993 | Reduce 27.35% | 5,295 | $149.58 |
| Q3 2020 | -43,863 | Reduce 85.75% | 7,288 | $132.14 |
| Q2 2020 | -1,943 | Reduce 3.66% | 51,151 | $115.89 |
| Q1 2020 | +53,094 | New Buy | 53,094 | $98.13 |
| Q2 2019 | -78,481 | Sold Out | 0 | $0.00 |
| Q1 2019 | +78,481 | New Buy | 78,481 | $123.98 |
| Q3 2018 | -79,383 | Sold Out | 0 | $0.00 |
| Q2 2018 | +79,383 | New Buy | 79,383 | $108.20 |
| Q1 2018 | -315,984 | Sold Out | 0 | $0.00 |
| Q4 2017 | +154,719 | Add 95.94% | 315,984 | $117.15 |
| Q3 2017 | +71,059 | Add 78.77% | 161,265 | $113.68 |
| Q2 2017 | -78,988 | Reduce 46.68% | 90,206 | $124.66 |
| Q1 2017 | +134,449 | Add 386.96% | 169,194 | $118.56 |
| Q4 2016 | -130,934 | Reduce 79.03% | 34,745 | $100.19 |
| Q3 2016 | -358,418 | Reduce 68.39% | 165,679 | $126.23 |
| Q2 2016 | +372,168 | Add 244.96% | 524,097 | $116.87 |
| Q1 2016 | +151,929 | New Buy | 151,929 | $103.52 |
| Q1 2015 | -3,796 | Sold Out | 0 | $0.00 |
| Q4 2014 | -755 | Reduce 16.59% | 3,796 | $110.12 |
| Q3 2014 | -219 | Reduce 4.59% | 4,551 | $97.56 |
| Q2 2014 | -42,195 | Reduce 89.84% | 4,770 | $100.84 |
| Q1 2014 | +44,193 | Add 1594.26% | 46,965 | $91.83 |
| Q4 2013 | -2,944 | Reduce 51.50% | 2,772 | $90.55 |
| Q3 2013 | -10,722 | Reduce 65.23% | 5,716 | $79.78 |
| Q2 2013 | +16,438 | Add 0.00% | 16,438 | $72.76 |
Joel Greenblatt's Zimmer Biomet Holdings Investment FAQs
Joel Greenblatt first purchased Zimmer Biomet Holdings, Inc. (ZBH) in Q2 2013, acquiring 16,438 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Zimmer Biomet Holdings, Inc. (ZBH) for 45 quarters since Q2 2013.
Joel Greenblatt's largest addition to Zimmer Biomet Holdings, Inc. (ZBH) was in Q2 2016, adding 524,097 shares worth $61.25 M.
According to the latest 13F filing for Q1 2026, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 52,832 shares of Zimmer Biomet Holdings, Inc. (ZBH), valued at approximately $4.78 M.
As of the Q1 2026 filing, Zimmer Biomet Holdings, Inc. (ZBH) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Zimmer Biomet Holdings, Inc. (ZBH) was 524,097 shares, as reported at the end of Q2 2016.